Skip to content
InsideEdge
Investors / filer profile

Track record

What happened ~6 months after each disclosed buy

-2.1%avg per buy, ~6 months on+13.7%S&P 500 avg, same spans
ACUT · 2025-06-11 · +36.7% (S&P +13.3%)ACUT · 2025-06-12 · -13.3% (S&P +13.3%)ACUT · 2025-06-13 · -29.7% (S&P +14.6%)
2025-06-112025-06-13
Each dot: one completed buy’s ~6-month outcome, equal weight per buy · dashed: S&P 500 over the same spans · hover a dot for detail
1 of 3
buys higher ~6mo later
-13.3%
median outcome
+13.3%
S&P 500 median, same spans

Disclosed positions

Estimated from their latest filings — positions may have changed since

$45.34M
combined est. value
TLSA
Tiziana Life Sciences Ltd
$44.32M
44,772,230 sh
ACUT
Accustem Sciences Inc.
$1.01M
6,502,400 sh

Activity

Open-market buy & sell volume

BuySell
0$10K$21K2025 · bought $21K · sold $02025
Total +$20.9K bought
Most bought
ACUT
$20.9K

All filings on record

Every Form 4 transaction we track for this filer

TLSAGrant
2026-06-12 · Tiziana Life Sciences Ltd
$16.6K
—
ACUTBuy
2025-06-13 · Accustem Sciences Inc.
$440.00
-29.7%
ACUTBuy
2025-06-13 · Accustem Sciences Inc.
$2.0K
-29.7%
ACUTBuy
2025-06-12 · Accustem Sciences Inc.
$7.5K
-13.3%
ACUTBuy
2025-06-11 · Accustem Sciences Inc.
$11.0K
+36.7%

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.